Positive liver cancer detection data published in Cancer Discovery1 demonstrates the promise of Delfi Diagnostics' high-performance, accessible liquid biopsy platform in a new tumor...
Biofluidica announced the results of a breast cancer study comparing invasive needle biopsies with their non-invasive, highly sensitive Next-Generation Liquid Biopsy platform, LiquidScan™ to...
